Funder
National Institute of Allergy and Infectious Diseases
Fogarty International Center
Office of Behavioral and Social Sciences Research
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Social Psychology
Reference46 articles.
1. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach (Second edition). Geneva: WHO; 2016. Available from: https://apps.who.int/iris/bitstream/10665/208825/1/9789241549684_eng.pdf?ua=1
2. World Health Organization. Programmatic update: Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. World Health Organization; 2012. Available from: https://www.who.int/hiv/PMTCT_update.pdf
3. Haroz D, von Zinkernagel D, Kiragu K. Development and impact of the global plan. JAIDS J Acquir Immune Defic Syndr. 2017;75:17–26.
4. Kalua T, Tippett Barr BA, van Oosterhout JJ, Mbori-Ngacha D, Schouten EJ, Gupta S, et al. Lessons Learned From Option B+ in the Evolution Toward “Test and Start” From Malawi, Cameroon, and the United Republic of Tanzania. JAIDS JAIDS J Acquir Immune Defic Syndr. 2017; Available from: https://journals.lww.com/jaids/Fulltext/2017/05011/Lessons_Learned_From_Option_B__in_the_Evolution.7.aspx
5. Kim MH, Ahmed S, Hosseinipour MC, Giordano TP, Chiao EY, Yu X, et al. Implementation and operational research: the impact of option B+ on the antenatal PMTCT cascade in Lilongwe. Malawi J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):e77–83.